Moreover, administration of a Tat peptide conjugated to an anti-apoptotic homology domain of a protein from the Bcl-2 family produces the same effect.
Use of cell membrane-permeant peptide conjugates as described herein provides a novel and potent therapeutic approach to the treatment of sepsis.